AVE avecho biotechnology limited

Ann: December 2024 Quarterly Activities Report & Appendix 4C, page-99

  1. 29,033 Posts.
    lightbulb Created with Sketch. 1538
    correct and at this stage in our endeavors there is a lot riding on these interim results. There is a possibility that these interim results, while not announced yet, are out now and hence the latest interest we have been witnessing. Leaked ...........always a possibility imo.

    If they do show such positivity and potential then it is fair to assume that someone with deep pockets(big pharma) is willing to cover costs for balance of trials with exclusivity rights if/when we can gain FDA approval

    Just wild thinking
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $12.69M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $1.259K 314.8K

Buyers (Bids)

No. Vol. Price($)
16 7225966 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31476906 26
View Market Depth
Last trade - 14.05pm 24/06/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.